Jane Street Group, LLC Ocuphire Pharma, Inc. Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.51 - $2.23 $63,986 - $94,496	42,375 New	42,375 $64,000
Q4 2023 Feb 14, 2024	BUY	$2.59 - $3.64 $89,849 - $126,275	34,691 New	34,691 $104,000
Q3 2021 Nov 16, 2021	SELL	$3.84 - $5.38 $95,938 - $134,413	-24,984 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.24 - $6.57 $105,932 - $164,144	24,984 New	24,984 $132,000

2.58M

14.1K

800

Ticker OCUP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,579,800
Market Cap $20.2M
Description
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.